This review does not presume to be exhaustive in the field of leukocyte elastase inhibitors. Instead, a general picture will be sketched to give the reader a brief update and encourage advances in this continuously growing sector of pharmacology, drug discovery and drug design. Three compounds with which the authors have direct experimental experience will be considered in detail as examples of newly emerging therapeutics from the ever-generous plant kingdom.